PharmacoEconomics

Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
pp. 409-427(19)
Authors: Crowley S.J.; Tognarini D.; Desmond P.V.; Lees M.

Healthcare Costs of Patients with Heart Failure Treated with Torasemide or Furosemide
pp. 429-440(12)
Authors: Stroupe K.T.; Forthofer M.M.; Brater D.C.; Murray M.D.

Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement
pp. 443-444(2)

Modelling in Health Economic Evaluation: What is its Place? What is its Value?
pp. 445-459(15)
Authors: Brennan A.; Akehurst R.

Assessing Quality in Decision Analytic Cost-Effectiveness Models: A Suggested Framework and Example of Application
pp. 461-477(17)
Authors: Sculpher M.; Fenwick E.; Claxton K.

Handling Uncertainty in Cost-Effectiveness Models
pp. 479-500(22)
Author: Briggs A.H.

Testing the Validity of Cost-Effectiveness Models
pp. 501-513(13)
Authors: McCabe C.; Dixon S.

Mirtazapine: A Pharmacoeconomic Review of its Use in Depression
pp. 515-534(20)
Authors: Holm K.J.; Jarvis B.; Foster R.H.